David Moatazedi

(Mr. David Moatazedi)

Currently holds positions in Obalon Therapeutics Inc and Evolus Inc

Positions

Position Company Period
Director Obalon Therapeutics Inc March 13, 2017 -
President, Chief Executive Officer, Director Evolus Inc May 6, 2018 -
David Moatazedi's trades of Evolus Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-28 2025-03-27
US Evolus Inc (EOLS)
PS Planned sale
6,251 -1.2%
12.40
USD 77,512 		6,251 -1.2% 12.40 USD 77,512
2025-03-20 2025-03-18
US Evolus Inc (EOLS)
PS Planned sale
103,376 -16.7%
13.26
USD 1,370,249 		103,376 -16.7% 13.26 USD 1,370,249
2024-12-26 2024-12-23
US Evolus Inc (EOLS)
PS Planned sale
10,502 -2.0%
10.85
USD 113,967 		10,502 -2.0% 10.85 USD 113,967
2024-06-06 2024-06-06
US Evolus Inc (EOLS)
S Sale
175,940 -24.8%
12.59
USD 2,214,486 		175,940 -24.8% 12.59 USD 2,214,486
2024-06-06 2024-06-05
US Evolus Inc (EOLS)
S Sale
155,278 -22.5%
12.92
USD 2,006,456 		155,278 -22.5% 12.92 USD 2,006,456
2024-06-06 2024-06-04
US Evolus Inc (EOLS)
S Sale
140,214 -20.8%
12.73
USD 1,784,686 		140,214 -20.8% 12.73 USD 1,784,686
2024-05-14 2024-05-10
US Evolus Inc (EOLS)
S Sale
16,051 -2.3%
12.72
USD 204,127 		16,051 -2.3% 12.72 USD 204,127
2024-03-29 2024-03-27
US Evolus Inc (EOLS)
S Sale
6,236 -0.9%
13.86
USD 86,431 		6,236 -0.9% 13.86 USD 86,431
2024-03-21 2024-03-19
US Evolus Inc (EOLS)
S Sale
96,566 -12.2%
13.92
USD 1,344,604 		96,566 -12.2% 13.92 USD 1,344,604
2024-02-23 2024-02-22
US Evolus Inc (EOLS)
PS Planned sale
7,706 -1.0%
13.08
USD 100,804 		7,706 -1.0% 13.08 USD 100,804
2023-12-08 2023-12-08
US Evolus Inc (EOLS)
S Sale
31,300 -4.9%
9.73
USD 304,505 		31,300 -4.9% 9.73 USD 304,505
2023-12-08 2023-12-06
US Evolus Inc (EOLS)
S Sale
51,348 -7.5%
10.09
USD 517,891 		51,348 -7.5% 10.09 USD 517,891
2023-08-16 2023-08-16
US Evolus Inc (EOLS)
PS Planned sale
14,778 -2.1%
10.27
USD 151,770 		14,778 -2.1% 10.27 USD 151,770
2023-03-29 2023-03-27
US Evolus Inc (EOLS)
PS Planned sale
6,110 -1.0%
8.47
USD 51,752 		6,110 -1.0% 8.47 USD 51,752
2023-03-16 2023-03-14
US Evolus Inc (EOLS)
PS Planned sale
64,211 -9.4%
8.47
USD 543,797 		64,211 -9.4% 8.47 USD 543,797
2022-05-18 2022-05-16
US Evolus Inc (EOLS)
S Sale
55,321 -10.1%
13.64
USD 754,307 		55,321 -10.1% 13.64 USD 754,307
2022-03-30 2022-03-28
US Evolus Inc (EOLS)
PS Planned sale
6,104 -1.1%
11.62
USD 70,928 		6,104 -1.1% 11.62 USD 70,928
2022-03-10 2022-03-08
US Evolus Inc (EOLS)
PS Planned sale
37,972 -6.4%
9.73
USD 369,293 		37,972 -6.4% 9.73 USD 369,293
2021-01-26 2021-01-25
US Evolus Inc (EOLS)
PS Planned sale
8,310 -4.6%
7.46
USD 61,993 		8,310 -4.6% 7.46 USD 61,993
// ... existing code ... // ... rest of the file ...